Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat | | monomer | 1-316 | 1×NAP; 1×TOL; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and sulindac | | monomer | 1-316 | 1×NAP; 1×SUZ; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008 | | monomer | 1-316 | 1×NAP; 1×UV8; 1×EDO; |
Assess |
Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat | | monomer | 1-316 | 1×NAP; 1×FID; 1×CL; |
Assess |
Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzyme | | monomer | 1-316 | 1×NAP; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and JF0049 | | monomer | 1-316 | 1×NAP; 1×F49; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319 | | monomer | 1-316 | 1×NAP; 2×1WX; 1×EDO; |
Assess |
Crystal structure of the methylated wild-type AKR1B10 holoenzyme | | monomer | 1-316 | 1×NAP; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388 | | monomer | 1-316 | 1×NAP; 1×388; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and JF0064 | | monomer | 1-316 | 1×NAP; 1×64I; |
Assess |
Crystal structure of AKR1B10 complexed with NADP+ | | monomer | 1-316 | 1×NAP; |
Assess |
Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil | | monomer | 1-316 | 1×NAP; 1×SBI; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184 | | monomer | 1-316 | 1×NAP; 1×MK4; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181 | | monomer | 1-316 | 1×NAP; 1×W8X; 1×EDO; |
Assess |
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204 | | monomer | 1-316 | 1×NAP; 1×DQP; 1×EDO; |
Assess |
Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester | | monomer | 1-316 | 1×QAP; 1×NAP; |
Assess |
Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid | | monomer | 1-316 | 1×FLF; 1×NAP; |
Assess |
Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat | | monomer | 1-316 | 1×NAP; 1×ZST; 1×NA; |
Assess |
Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestat | | monomer | 1-316 | 1×EPR; 1×NAP; |
Assess |
Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol | | monomer | 4-316 | 1×NAP; 1×8QL; |
Assess |